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(PVR) from a previously described formula using preejectlon time, acceleration time and heart failure, and sudden death. The recovery of circadian regulation of HRV detected 
total systolic time. Right atrial pressure (RAP) was estimated from respiratory change of after long-term TS may be mediated by an improvement in central hemodynamics as a 
the vena cava inferior. result of TS therapy. 
Results: see table. ‘p<O.O5 vs baseline, fp<0.05 vs. NO / Sil. On the next morning, mea- 
surements returned to baseline values. “T 
LOW/HIGH FREOUENCY RATIO 
Conclusion : Inhibition of PDE-5 reduces pulmonary hypertension to a similar extent as 
NO. As expected, the 2 agents have synergistic effects. Thus, PDE-5 inhibitors may be 
candidates for prevention of high-altitude pulmonary edema in susceptible mountaineers. 
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811-3 Prognostic Value of Transthoracic Echocardiography in 
Massive Pulmonary Embolism: A Retrospective Study 
of 617 Patients 
HOUR 
Gerard D. Pacouret E. Hamel, M. Montout. D. Djeffal Vincentelli, 6. Charbonnier, 
Trousseau Hospital, Tours, France 
Noon 
Right ventricular dilation induced by massive pulmonary embolism (PE) can be easily 
detected, at bedside, by trans-thoracic echocardiography (EC). To test the prognostic 
value of this parameter, we retrospectively analyzed a population of 617 consecutive 
patients admitted to our institution for acute massive PE, and who were evaluated by EC 
at baseline. Massive PE was defined as angiographic Miller index t 20/34 and/or pedu- 
sion lung scan defect 2 40 % and/or bilateral central PE on helicoidal CT scan. 
Results : Right ventricle/left ventricle end diastolic diameter ratio (RVILV), calculated 
from the long axis parasternal view, the subcostal view or the apical 4 chamber view in 
supine position was assessable in 546 patients ( 89 % ), 27 pts died during the index 
hospitalization (4.4 %). Univariate analysis revealed that among 7 parameters, only sys- 
temic hypotension and RV/LV were significantly associated with the risk of death (see 
table). 
After adjustment to systemic hypotension, contra-indication to thrombolysis and throm- 
bolysis, RVILV appeared as an independent predictor of in-hospital death (p=O.O06) in 
multivariate analysis. 
Conclusion : RVILV end-diastolic diameter ratio is an independent predictor of in-hospi- 
tal death in patients suffering from acute massive PE. Thrombolysis could be beneficial in 
such patients when RVILV > 0.8, even in the absence of hypotension. A prospective ran- 
811-5 Long-Term Survival Comparison in Patients With 
Primary and Secondary Pulmonary Arterial 
Hypertension Treated With Chronic Epoprostenol 
Therapy 
Maninder S. Sedi, Jessica Spates-Panyon, Michael M. Mathier. AJOY Kapoor. Guy A. 
MacGowan, Dennis M. McNamara, Srinivas Murali, University of Pittsburgh, Ptttsburgh, 
PA 
Pulmonary arterial hypertension (PH), whether primary (P) or secondary (S) due to sys- 
temic sclerosis (SS) has a poor prognosis. Epoprostenol (E) therapy improves symptoms 
and survival in PH, though it is not known if the survival benefit from E is different in PPH 
and SPH patients (pts). 
Methods: Baseline hemodynamics (prior to E therapy) and outcomes were assessed in 
92 PH pts (Grp A: PPH, ~81, age 44.3~ 11.8 years, 87% female, NYHA Class III/ IV 571 
28%; Grp B: SPH, n=31, age 52.8i 11 years, 74% female, NYHA Class III/ IV 45132%) 
treated with E infusion. Both Grps had normal baseline resting left ventricular ejection 
fraction (Grp A: 57+5%, Grp B: 55*5 %). Doses of E were comparable (Grp A: 58i33, 
Grp B: 572.37 ng/kg/min) and pts were followed for 8091 625 days (range 8-3256 days). 
Results: At baseline, Grp A had significantly higher (~~0.05) pulmonary artery (PA) dias- 
tolic (38.6tl0.9/32.8*7.6mmHg), PA Mean (56.4+13.7/49.9+8.8 mmHg) pressures com- 
pared to Grp B. Right Atrial and PA systolic pressures, Cardiac index and pulmonary 
Vascular resistance were comparable in the Grps. During follow-up, 16(26%) Grp A and 
3(10%) Grp B pts underwent pulmonary transplantation and 19(31%) Grp A and 11(36%) 
Grp B pts died. The one, two and five year transplant free survival (figure) in the two Grps 
was comparable (Grp A: 82/59/35%: Grp B: 69/67/38%, p=O.4). 
Conclusion: Lona-term suwival on E theraov is similar in PPH and SPH due to SS. 
despite higher PA pressures in PPH pts at initial presentation. 
domized study is mandatory to confirm this hypothesis. 
Umvariate Analysis Of In-Hospml Risk Factors 
Death Alive 
n=27 n=590 
Age (95% Cl ) 73.4 (66.4- 71.4 (70.4. 
78.4) 72.4) 
Gender (M/P) (n) 8/l 9 239/351 
Previous Thrombo-E mbolism (n) 10 219 
Contra-indication to Thrombolysis (n) 14 228 
Thrombolysis (n) 11 169 
RWLV (95% Cl) 1.00 (0.82- 0.79 (0.77. 
1.17) 0.81) 
Systemic Hypotension (n) 12 101 
P 
0.41 
0.31 
> 0.99 
0.23 
0.20 
< 0.0001 
0.001 
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811-4 Effect of Treprostinil Sodium on Circadian Regulation of 
Heart Rate Variability in Primary Pulmonary 
Hypertension 
Martin P. Aosas, Julio Sandoval, Nuria Granados, Fause Attie, Tomas Pulido, Teresa 
Miranda, EfrCn Santos, lnstituto National de Cardiologia lgnacio Chavez, Mexico City, 
MlXiW 
Background: A reduction of heart rate variability (HRV) is now considered as an inde- 
pendent risk factor for morbidity, mortality and severity of several cardiac diseases; how- 
ever, the dynamic sympathovagal modulation on HRV during 24 hr in primary pulmonary 
hypertension (PPH) and the therapeutic impact of Treprostinil Sodium (TS) on this modu- 
lation has not been described. 
Methods: 24 hr-Halter monitoring (HM) were recorded in 15 patients (mean age 34 f 12; 
90% female) with severe PPH (mean pulmonary pressure = 70 + 12 mm Hg), before and 
after three months of therapy with subcutaneous TS. The HRV time and spectral param- 
eters (mean, SDNN, SDANN, rMSSD. PNN50, LF, HF and LF/HF ratio) were analyzed 
during three periods: 24 hr: Day (8-2200) night (23.07:OO) and also during every hour of 
recording (5 min-intervals). 
Results: Circadian rhythm of HRV is clearly disturbed in PPH (increased sympathetic 
tone) as compared to normal control subjects (p < 0.05). Frequency parameters of HRV 
during 24 hr-HM were significantly different before and after long-term subcutaneous TS 
administration (Figure). 
Conclusions: The circadian rhythm of HRV in PPH is lost mainly due to an increase of 
sympathetic tone. This autonomic imbalance may favor the development of arrhythmia, 
